Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Testicular Neoplasms 2Neoplasms 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Seminoma 1Oropharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hearing Loss 1Carcinoma 1Anosmia 1Adenocarcinoma 1

Interventions

Cisplatin 20Surgical Procedures, Operative 9Docetaxel 8Cetuximab 8Radiotherapy, Intensity-Modulated 7Magnetic Resonance Spectroscopy 6pembrolizumab 5Specimen Handling 5Radiotherapy 5Fluorouracil 5toripalimab 4Surveys and Questionnaires 4Radiation 4Paclitaxel 4Chemoradiotherapy 4Celecoxib 4X-Rays 3Platinum 3Counseling 3Carboplatin 3130-nm albumin-bound paclitaxel 31,2-diaminocyclohexaneplatinum II citrate 3camrelizumab 2Taxes 2Standard of Care 2Psychiatric Rehabilitation 2Practice Guidelines as Topic 2Neoadjuvant Therapy 2Narrow Band Imaging 2Interviews as Topic 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hypopharyngeal Neoplasms × Hearing × Clear all
NCT06662058 2026-04-23

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Emory University

Phase NA Recruiting
118 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡